Skip to Main Content

Paper Details

The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer.
Biomedicines
12
2022
CRPC, Prostate Cancer, Prostate cancer, androgen, androgen receptor, antigen, antigen-presenting and cytotoxic T-cell, castration-resistant prostate cancer, chimeric, chimeric antigen receptor-T (CAR-T) cells, malignant tumors, men, patients, prostate cancer, tumor
Author NameAffiliation
Christopher P EvansUniversity of California Davis
Christopher P EvansUC Davis Comprehensive Cancer Center, University of California Davis
William J MurphyUC Davis Comprehensive Cancer Center, University of California Davis
William J MurphyUniversity of California Davis
  • 1 - 4

Datasets

Release 1.2